Descripción de negocio
Formycon is a leading and independent developer of biosimilar drugs, meeting the highest quality standards, for marketing and distribution around the globe. The company spans the entire pharmaceutical value creation chain all the way through to phase III clinical trials and registration. Formycon specifically develops biosimilars to meet the stringent standards required for regulatory approval in the most highly regulated markets (EU, U.S., Japan, Canada, Australia), and positions itself as preferred partner for major pharmaceutical and generic corporations.
Consejo de gestión & Consejo de supervisión
| CEO |
| Stefan Glombitza |
| Consejo de gestión |
| Enno Spillner, Nicola Mikulcik, Andreas Seidl |
| Consejo de supervisión |
| Wolfgang Essler, Nicholas Haggar, Klaus Röhrig, Bodo Coldewey, Colin Bond |
Datos de la empresa
| Nombre: |
Formycon AG |
| Dirección: |
Fraunhoferstraße 15,D-82152 Martinsried/Planegg |
| Teléfono: |
+49-89-864667-100 |
| Fax: |
+49-89-864667-110 |
| E-mail: |
info@formycon.com
|
| Internet: |
www.formycon.com |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
36.20% |
| Fecha de OPI: |
20/12/2010 |
Relación con inversores
| Nombre: |
Sabrina Müller |
| IR teléfono: |
+49-89-864667-149 |
| IR-fax: |
+ 49 89 86 46 67 110 |
| IR e-mail: |
sabrina.mueller@formycon.com
|